385 related articles for article (PubMed ID: 30506232)
41. Possible Relevance of PNPLA3 and TLL1 Gene Polymorphisms to the Efficacy of PEG-IFN Therapy for HBV-Infected Patients.
Enomoto H; Aizawa N; Hasegawa K; Ikeda N; Sakai Y; Yoh K; Takata R; Yuri Y; Kishino K; Shimono Y; Ishii N; Takashima T; Nishimura T; Nishikawa H; Iwata Y; Iijima H; Nishiguchi S
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349377
[TBL] [Abstract][Full Text] [Related]
42. IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
Li N; Zhu Q; Li Z; Han Q; Zhang G; Chen J; Lv Y; Xing F; Chen Y; Zeng X; Liu Z
Mol Carcinog; 2014 Jun; 53(6):447-57. PubMed ID: 23280722
[TBL] [Abstract][Full Text] [Related]
43. miR-516a-3P, a potential circulating biomarker in hepatocellular carcinoma, correlated with
Youssef SS; Youness RA; Abbas EAE; Osman NM; ELFiky A; El-Kassas M
Per Med; 2022 Nov; 19(6):483-493. PubMed ID: 36239555
[TBL] [Abstract][Full Text] [Related]
44. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
45. Impact of the PNPLA3 genotype on the risk of hepatocellular carcinoma after hepatitis C virus eradication.
Ohta A; Ogawa E; Murata M; Matsumoto Y; Yamasaki S; Ikezaki H; Furusyo N
J Med Virol; 2022 Oct; 94(10):5007-5014. PubMed ID: 35652276
[TBL] [Abstract][Full Text] [Related]
46. Single-nucleotide rs738409 polymorphisms in the PNPLA3 gene are strongly associated with alcoholic liver disease in Han Chinese males.
Zhang Y; Guo T; Yang F; Mao Y; Li L; Liu C; Sun Q; Li Y; Huang J
Hepatol Int; 2018 Sep; 12(5):429-437. PubMed ID: 30132178
[TBL] [Abstract][Full Text] [Related]
47. Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data.
Trépo E; Nahon P; Bontempi G; Valenti L; Falleti E; Nischalke HD; Hamza S; Corradini SG; Burza MA; Guyot E; Donati B; Spengler U; Hillon P; Toniutto P; Henrion J; Franchimont D; Devière J; Mathurin P; Moreno C; Romeo S; Deltenre P
Hepatology; 2014 Jun; 59(6):2170-7. PubMed ID: 24114809
[TBL] [Abstract][Full Text] [Related]
48. The adiponutrin I148M variant is a risk factor for HCV-associated liver cancer in North-African patients.
Ezzikouri S; Alaoui R; Tazi S; Nadir S; Elmdaghri N; Pineau P; Benjelloun S
Infect Genet Evol; 2014 Jan; 21():179-83. PubMed ID: 24269995
[TBL] [Abstract][Full Text] [Related]
49. Additive Effects of the Risk Alleles of PNPLA3 and TM6SF2 on Non-alcoholic Fatty Liver Disease (NAFLD) in a Chinese Population.
Wang X; Liu Z; Wang K; Wang Z; Sun X; Zhong L; Deng G; Song G; Sun B; Peng Z; Liu W
Front Genet; 2016; 7():140. PubMed ID: 27532011
[TBL] [Abstract][Full Text] [Related]
50. Gene polymorphisms of interleukin 28B and the risk to chronic hepatitis B virus infection in Thai.
Kimkong I; Chankaew J; Kunanopparat A; Hirankarn N; Tangkijvanich P
Tissue Antigens; 2015 Mar; 85(3):177-81. PubMed ID: 25664396
[TBL] [Abstract][Full Text] [Related]
51. Association of PINX1 but not TEP1 Polymorphisms with Progression to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B Virus Infection.
Sriprapun M; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Tangkijvanich P
Asian Pac J Cancer Prev; 2016; 17(4):2019-25. PubMed ID: 27221889
[TBL] [Abstract][Full Text] [Related]
52. Donor PNPLA3 and TM6SF2 Variant Alleles Confer Additive Risks for Graft Steatosis After Liver Transplantation.
Míková I; Neřoldová M; Hubáček JA; Dlouhá D; Jirsa M; Honsová E; Sticová E; Lánská V; Špičák J; Trunečka P
Transplantation; 2020 Mar; 104(3):526-534. PubMed ID: 31356578
[TBL] [Abstract][Full Text] [Related]
53. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction.
Hassan MM; Kaseb A; Etzel CJ; El-Serag H; Spitz MR; Chang P; Hale KS; Liu M; Rashid A; Shama M; Abbruzzese JL; Loyer EM; Kaur H; Hassabo HM; Vauthey JN; Wray CJ; Hassan BS; Patt YZ; Hawk E; Soliman KM; Li D
Mol Carcinog; 2013 Nov; 52 Suppl 1(0):E139-47. PubMed ID: 23776098
[TBL] [Abstract][Full Text] [Related]
54. PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma.
Valenti L; Motta BM; Soardo G; Iavarone M; Donati B; Sangiovanni A; Carnelutti A; Dongiovanni P; Rametta R; Bertelli C; Facchetti F; Colombo M; Fargion S; Fracanzani AL
PLoS One; 2013; 8(10):e75982. PubMed ID: 24155878
[TBL] [Abstract][Full Text] [Related]
55. Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease.
Koo BK; Joo SK; Kim D; Bae JM; Park JH; Kim JH; Kim W
J Gastroenterol Hepatol; 2018 Jun; 33(6):1277-1285. PubMed ID: 29193269
[TBL] [Abstract][Full Text] [Related]
56. TNIP1 Polymorphisms with the Risk of Hepatocellular Carcinoma Based on Chronic Hepatitis B Infection in Chinese Han Population.
Cheng Y; Jiang X; Jin J; Luo X; Chen W; Li Q; Zhang C
Biochem Genet; 2019 Feb; 57(1):117-128. PubMed ID: 30073579
[TBL] [Abstract][Full Text] [Related]
57. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
[TBL] [Abstract][Full Text] [Related]
58. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.
Kim SS; Cho HJ; Lee HY; Park JH; Noh CK; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
Clin Biochem; 2016 Jul; 49(10-11):792-801. PubMed ID: 26968103
[TBL] [Abstract][Full Text] [Related]
59. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
[TBL] [Abstract][Full Text] [Related]
60. Association of NTCP polymorphisms with clinical outcome of hepatitis B infection in Thai individuals.
Chuaypen N; Tuyapala N; Pinjaroen N; Payungporn S; Tangkijvanich P
BMC Med Genet; 2019 May; 20(1):87. PubMed ID: 31117968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
